M.F. Frecker

467 total citations
12 papers, 325 citations indexed

About

M.F. Frecker is a scholar working on Physiology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, M.F. Frecker has authored 12 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in M.F. Frecker's work include Ophthalmology and Eye Disorders (3 papers), Alzheimer's disease research and treatments (3 papers) and Diabetes and associated disorders (2 papers). M.F. Frecker is often cited by papers focused on Ophthalmology and Eye Disorders (3 papers), Alzheimer's disease research and treatments (3 papers) and Diabetes and associated disorders (2 papers). M.F. Frecker collaborates with scholars based in Canada, Hungary and India. M.F. Frecker's co-authors include F. Clarke Fraser, James K. Friel, F. Clarke Fraser, Nadir R. Farid, V. Stenszky, László Kozma, Verna M. Skanes, P. W. Allderdice, Elizabeth Ives and H. Dawn Marshall and has published in prestigious journals such as Journal of Epidemiology & Community Health, Clinical Endocrinology and Human Genetics.

In The Last Decade

M.F. Frecker

12 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.F. Frecker Canada 10 100 92 70 66 59 12 325
Tsunesuke Shimotsuji Japan 12 63 0.6× 92 1.0× 80 1.1× 73 1.1× 75 1.3× 31 466
M Bayer Czechia 8 47 0.5× 63 0.7× 36 0.5× 43 0.7× 32 0.5× 16 287
Sara Peralta Spain 10 38 0.4× 102 1.1× 31 0.4× 39 0.6× 38 0.6× 26 364
Somkietr Rojanasathit United States 8 30 0.3× 43 0.5× 58 0.8× 69 1.0× 55 0.9× 8 370
Lurdes Lopes Portugal 10 84 0.8× 335 3.6× 82 1.2× 78 1.2× 19 0.3× 34 552
Jovana Kaludjerovic Canada 14 48 0.5× 43 0.5× 127 1.8× 48 0.7× 98 1.7× 23 559
L. Garbaczewski United States 13 24 0.2× 65 0.7× 76 1.1× 162 2.5× 47 0.8× 21 489
Fatih Kardaş Türkiye 11 22 0.2× 77 0.8× 34 0.5× 27 0.4× 27 0.5× 47 367
Ying-King Wu United States 11 90 0.9× 37 0.4× 49 0.7× 33 0.5× 273 4.6× 12 525
Mohammad Al-Haggar Egypt 11 30 0.3× 30 0.3× 53 0.8× 17 0.3× 81 1.4× 47 330

Countries citing papers authored by M.F. Frecker

Since Specialization
Citations

This map shows the geographic impact of M.F. Frecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.F. Frecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.F. Frecker more than expected).

Fields of papers citing papers by M.F. Frecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.F. Frecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.F. Frecker. The network helps show where M.F. Frecker may publish in the future.

Co-authorship network of co-authors of M.F. Frecker

This figure shows the co-authorship network connecting the top 25 collaborators of M.F. Frecker. A scholar is included among the top collaborators of M.F. Frecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.F. Frecker. M.F. Frecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Moore, S. Jo, H. Dawn Marshall, Leslie Steele, et al.. (2008). The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland. Clinical Genetics. 74(3). 213–222. 51 indexed citations
2.
Friel, James K., M.F. Frecker, & F. Clarke Fraser. (1995). Nutritional patterns of mothers of children with neural tube defects in Newfoundland. American Journal of Medical Genetics. 55(2). 195–199. 59 indexed citations
3.
Frecker, M.F., et al.. (1994). Immunological Associations in Familial and Non-Familial Alzheimer Patients and Their Families. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 21(2). 112–119. 12 indexed citations
4.
Frecker, M.F.. (1991). Dementia in Newfoundland: identification of a geographical isolate?. Journal of Epidemiology & Community Health. 45(4). 307–311. 34 indexed citations
5.
Frecker, M.F., F. Clarke Fraser, E. Andermann, & William Pryse‐Phillips. (1990). Association Between Alzheimer Disease and Amyotrophic Lateral Sclerosis?. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 17(1). 12–14. 12 indexed citations
6.
Frecker, M.F., et al.. (1988). Major Histocompatibility Complex (MHC) Factors Predisposing to and Protecting Against Graves' Eye Disease. Autoimmunity. 1(4). 307–315. 27 indexed citations
7.
Frecker, M.F. & F. Clarke Fraser. (1987). Epidemiological studies of neural tube defects in Newfoundland. Teratology. 36(3). 355–361. 28 indexed citations
8.
Fraser, F. Clarke, M.F. Frecker, & P. W. Allderdice. (1986). Seasonal variation of neural tube defects in Newfoundland and elsewhere. Teratology. 33(3). 299–303. 19 indexed citations
9.
Frecker, M.F., et al.. (1986). GENETIC FACTORS IN GRAVES' OPHTHALMOPATHY. Clinical Endocrinology. 25(5). 479–485. 64 indexed citations
10.
Frecker, M.F., M. Preus, László Kozma, et al.. (1986). Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.. PubMed. 3(1). 63–71. 6 indexed citations
11.
Preus, M., et al.. (1985). A PROGNOSTIC SCORE FOR Graves' DISEASE. Clinical Endocrinology. 23(6). 653–661. 9 indexed citations
12.
Frecker, M.F., et al.. (1978). Confirmation of regional assignment of nucleoside phosphorylase (NP) on chromosome 14 by gene dosage studies. Human Genetics. 45(2). 167–173. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026